* Vivani Medical Inc VANI.OQ VANI.O is expected
to report
results on August 7 (estimated).
*
* Refinitiv's mean analyst estimate for Vivani Medical Inc
is for
a loss of 11 cents per share.
* The one available analyst rating on the shares is "buy".
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "Buy".
* Wall Street's median 12-month price target for Vivani
Medical
Inc is $4, above its last closing price of $1.30.
This summary was machine generated August 4 at 10:18 GMT. All
figures in US dollars unless otherwise stated